NeoGenomics（納斯達克代碼：NEO）報告季度每股收益爲0.04美元，高於分析師一致預期的0.03美元，超出33.33%。這比去年同期的每股收益增加了33.33%。公司報告季度銷售額爲1.72億美元，低於分析師一致預期的1.7318億美元，低出0.68%。這比去年同期的銷售額1.5555億美元增加了10.57%。

以上內容來自Benzinga Earnings專欄，原文如下：

NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. This is a 33.33 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $172.00 million which missed the analyst consensus estimate of $173.18 million by 0.68 percent. This is a 10.57 percent increase over sales of $155.55 million the same period last year.